Jan 21, 2026
Which monoclonal antibody therapies remain effective against current Omicron sublineages and where are antivirals available locally?
that were effective early in the pandemic have lost potency against successive , and by late 2022–2024 many authorized anti‑Spike mAbs show markedly reduced neutralizing activity against newer lineage...